Prostate embolization: patient selection, clinical management and results.
Shamar Young, Jafar Golzarian
https://pubmed.ncbi.nlm.nih.gov/32027007/Actively Recruiting
Led by Uppsala University · Updated on 2026-10-02
104
Participants Needed
4
Research Sites
104 weeks
Total Duration
Researchers are evaluating treatments for benign prostatic hyperplasia, a condition causing lower urinary tract symptoms. The study compares two procedures, Prostate Artery Embolization PAE and Transurethral Prostate Resection TURP, focusing on their effects on symptom improvement, complications, costs, and quality of life. This open multicentric randomized trial aims to assess both medical and health economic outcomes related to these treatments. The study involves two groups one receiving PAE, where experienced interventional radiologists perform catheterization of prostate vessels using microspheres to block blood flow, and the other receiving TURP, a surgical procedure using a resectoscope to cut and remove prostate tissue via the urethra under anesthesia. Both interventions are delivered in hospital settings by specialized medical teams. Participants will be monitored over 24 months with assessments including urinary symptom scores IPSS, health care costs, adverse effects, quality of life surveys EQ-5D-5L, erectile function, and prostate-specific antigen PSA levels. The study measures changes in symptoms and health economics while tracking safety and quality of life throughout the follow-up period. Total participation may last up to two years.
CONDITIONS
Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE)
E
Emir Majbar, MD
F
Farhood Alamdari, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Uppsala University
Lead Sponsor
Centrallasarettet Västerås
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 24 months
Participants receive either Prostate Artery Embolization (PAE) or Transurethral Prostate Resection (TURP) as assigned. Both procedures are performed by specialists to treat prostate enlargement.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Shamar Young, Jafar Golzarian
https://pubmed.ncbi.nlm.nih.gov/32027007/D J Hunter, M McKee, N A Black...
https://pubmed.ncbi.nlm.nih.gov/7539561/W M Garraway, G N Collins, R J Lee
https://pubmed.ncbi.nlm.nih.gov/1714529/Francisco Cesar Carnevale, Alberto Azoubel Antunes, Joaquim Mauricio da Motta Leal Filho...
https://pubmed.ncbi.nlm.nih.gov/19908092/M J Barry, F J Fowler, M P O'Leary...
https://pubmed.ncbi.nlm.nih.gov/1279218/Uppsala University
Lead Sponsor
Centrallasarettet Västerås
Collaborating Sponsor